NFKB1 and Miyoshi myopathy: Here, we first observed reduced NF-kB activation in MM cells lacking GAS6 and after treatment with GAS6 depleted-BMSC-CM, thus revealing that TAM receptor signaling controls NF-kB activity in these tumor cells.